Companies / Amgen
Amgen
AMGN United States
ID 49 · CIK 318154 · reconciled 2026-10-10T16:40
SEC EDGAR filings ↗ Raw model extractions
Employees (legacy)
Revenue FY2025
36.8B
▲ 10.0% vs FY2024
Net profit FY2025
7.7B
▲ 88.5% vs FY2024
Total assets FY2025
90.6B
▼ 1.4% vs FY2024
Stockholders' equity FY2025
8.7B
▲ 47.3% vs FY2024
Operating cash flow FY2025
10.0B
▼ 13.3% vs FY2024
EPS (diluted) FY2025
14.23
▲ 88.2% vs FY2024
Employees FY2025
31,500
▲ 12.5% vs FY2024
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
All entities
Segment data comes from F4: entity names are clustered across models with Qwen, then each period is a majority vote.
Unlike F1–F3 there is no 2-model minimum — hover a value to see how many models reported it.
Vote results
| Source | Validated | Discarded | Calculated | Empty | Discard rate |
|---|---|---|---|---|---|
| F1 · income statement | 1,391 | 184 | 304 | 439 | 11.7% |
| F2 · balance sheet | 2,369 | 268 | 0 | 1,083 | 10.2% |
| F3 · cash flow | 509 | 22 | 716 | 275 | 4.1% |
| F5 · human capital | 68 | 30 | 0 | 367 | 30.6% |
Re-run plan for this company
| Action | Source | Form | Period end | Accession | Tier | Fields | Missing models |
|---|---|---|---|---|---|---|---|
| run third ai | F1 | 10-K | 2008-12-31 | 0001193125-09-041091 | 2 | shares_outstanding | no-ai-xblr |
| third ai optional | F1 | 10-Q | 1997-03-31 | 0000318154-97-000008 | 4 | eps_basic[3mo], eps_basic[ytd] | no-ai-xblr |
| third ai optional | F1 | 10-Q | 1997-06-30 | 0000318154-97-000016 | 4 | eps_basic[3mo], eps_basic[ytd] | no-ai-xblr |
| third ai optional | F1 | 10-Q | 1997-09-30 | 0000318154-97-000019 | 4 | eps_basic[3mo], eps_basic[ytd] | no-ai-xblr |
| third ai optional | F1 | 10-Q | 2002-06-30 | 0000898430-02-003028 | 4 | shares_outstanding | no-ai-xblr |
| run third ai | F2 | 10-K | 2004-12-31 | 0000950129-05-002159 | 2 | long_term_debt | no-ai-xblr |
| run third ai | F2 | 10-K | 2005-12-31 | 0001104659-06-015851 | 2 | long_term_debt | no-ai-xblr |
| skip | F2 | 10-Q | 2000-03-31 | 0000898430-00-001375 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 2010-06-30 | 0000950123-10-074870 | total_liabilities | ||
| third ai optional | F2 | 10-Q | 2008-03-31 | 0001193125-08-110189 | 4 | long_term_debt | no-ai-xblr |
| run third ai | F5 | 10-K | 2013-12-31 | 0000318154-14-000004 | 2 | employees_total | |
| run third ai | F5 | 10-K | 2014-12-31 | 0000318154-15-000005 | 2 | employees_total | |
| run third ai | F5 | 10-K | 2015-12-31 | 0000318154-16-000031 | 2 | employees_total | |
| run third ai | F5 | 10-K | 2016-12-31 | 0000318154-17-000004 | 2 | employees_total | |
| run third ai | F5 | 10-K | 2017-12-31 | 0000318154-18-000004 | 2 | employees_total | |
| run third ai | F5 | 10-K | 2018-12-31 | 0000318154-19-000008 | 2 | employees_total | |
| run third ai | F5 | 10-K | 2019-12-31 | 0000318154-20-000017 | 2 | employees_total | |
| run third ai | F5 | 10-K | 2012-12-31 | 0001445305-13-000364 | 2 | employees_total |